Empowering Innovation in Emerging Therapeutics
For more than 20 years, AcuraBio has been a world leader in microbial biopharmaceutical manufacturing, specializing in recombinant proteins and vaccines, and complex live therapeutic products for the biotech, pharmaceutical, and veterinary industries. That makes us one of Australia’s most experienced biopharmaceutical CDMOs, with the manufacturing facility to match.
Because of our proven technical brilliance and ability to adapt our systems and processes to your individual needs, we don’t use a cookie-cutter approach to anything we do for you. We’ll embrace your project as our own and make it our priority while delivering it to the highest quality standards.
AcuraBio carries out microbial aerobic and anaerobic fermentation, yeast fermentation, technical transfer, cell banking, process development and validation, analytical development, cGMP production, and stability studies for BSL-1 and BSL-2 organisms.
See Our Facility Layout:
Download a AcuraBio Fact Sheet for Quick Reference